Correlation Between Biofil Chemicals and Generic Engineering

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Generic Engineering at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Generic Engineering into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Generic Engineering Construction, you can compare the effects of market volatilities on Biofil Chemicals and Generic Engineering and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Generic Engineering. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Generic Engineering.

Diversification Opportunities for Biofil Chemicals and Generic Engineering

0.38

Correlation Coefficient

Biofil Chemicals  Generic Engineering

Weak diversification

The 3 months correlation between Biofil and Generic is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Generic Engineering Constructi in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generic Engineering and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Generic Engineering. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generic Engineering has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Generic Engineering go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Generic Engineering

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to generate 1.72 times more return on investment than Generic Engineering. However, Biofil Chemicals is 1.72 times more volatile than Generic Engineering Construction. It trades about 0.03 of its potential returns per unit of risk. Generic Engineering Construction is currently generating about -0.1 per unit of risk. If you would invest  6,369  in Biofil Chemicals Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  225.00  from holding Biofil Chemicals Pharmaceuticals or generate 3.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Generic Engineering Constructi

Biofil Chemicals Pha

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Biofil Chemicals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Generic Engineering

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Generic Engineering Construction has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Biofil Chemicals and Generic Engineering

The main advantage of trading using opposite Biofil Chemicals and Generic Engineering positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Generic Engineering can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generic Engineering will offset losses from the drop in Generic Engineering's long position.

The idea behind Biofil Chemicals Pharmaceuticals and Generic Engineering Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.